Healthcare -
Biotechnology - NASDAQ - US
$ 40.26
-1.18 %
$ 7.48 B
Market Cap
-11.25
P/E
RVMD - LONG-TERM DEBT
Long-term Debt RVMD - Revolution Medicines, Inc.
80.6 M
LAST VALUE
15.48%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR